CXCL13 Protein (AA 23-94)
Quick Overview for CXCL13 Protein (AA 23-94) (ABIN2666638)
抗原
See all CXCL13 蛋白蛋白类型
生物活性
宿主
资源
应用范围
纯度
-
-
产品特性
- AA 23-94
-
过滤
- 0.22 μm filtered
-
内毒素水平
-
Less than 0.01 ng per μg cytokine as determined by the LAL method.
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
Biological activity: Bioactivity was measured by its property to chemoattract Baf3-hCXCR5 transfectants in a dose dependent manner.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
溶解方式
- For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored from -20 °C to -70 °C. Stock solutions can also be prepared at 50-100 μg/mL in sterile buffer (PBS, HPBS, DPBS, or EBSS) containing carrier protein such as 0.2-1 % BSA or HSA and stored in working aliquots at -20 °C to -70 °C.
-
缓冲液
- 0.22 μm filtered protein solution is in PBS.
-
注意事项
- Avoid repeated freeze/thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- Unopened vial can be stored between 2°C and 8°C for one month, at -20°C for six months, or at -70°C for one year.
-
-
- CXCL13 (Chemokine (C-X-C Motif) Ligand 13 (CXCL13))
-
别名
- CXCL13
-
背景
- CXCL13 was initially described as a chemokine highly expressed in the follicles of Peyer's patches, spleen, and lymph nodes and as a strong chomoattractant for B cells. CXCL13 is expressed by T follicular helper cells, dendritic cells, and stromal cells in B cell areas of secondary lymphoid tissue. CXCR5, the receptor for CXCL13, was initially cloned from Burkitt's lymphoma cells and named BLR1. CXCR5 is highly expressed in those cells and B cells. CXCL13, CCL19, and CCL21 are involved in the formation of tertiary lymphoid tissues in chronic antigen-induced arthritis. CXCL13 takes part in the allergic airway inflammatory process. In addition, high expression of CXCL13 has been linked to lupus, Helicobacter pylori-associated gastritis, multiple sclerosis, and rheumatoid arthritis. In summary, CXCL13 is highly expressed at the sites of new lymphoid tissue formation in a variety of chronic inflammatory conditions.
-
分子量
- The 72 amino acid recombinant protein has a predicted molecular mass of approximately 8.6 kDa. The DTT-reduced and non-reduced protein migrate at approximately 12 kDa by SDS-PAGE. The N-terminal amino acid is Val.
抗原
-